Prevalence and Risk Factors of Hypertension Among Young Adults (26-35 Years Old) in Indonesia: Analysis of Secondary Data from Riskesdas 2018

Background Worldwide, there are 54% adults diagnosed with hypertension. The prevalence of hypertension increased, based on the basic health survey (Riset Kesehatan Dasar; RISKESDAS) in 2013, the prevalence of hypertension was 25.8%, while the on the RISKESDAS 2018 data increased to 34.1%. This research aimed to find out the risk factors of hypertension among young adults in Indonesia using RISKESDAS 2018 data.

The research design approach observational quantitative by cross-sectional design. This research used secondary data from RISKESDAS 2018 with a total of 140,073 subjects aged 26-35 years. All subjects who fulfil the inclusion criteria will be analyzed (n=78,000). Data analysed by chi-square test and binary logistic regression.

The result of research exposed gender (p<0.001), marital status (p<0.001), education levels (p<0.001), working status (p<0.001), BMI (p<0.001), diabetes mellitus (p<0.001), emotional mental disorder (p<0.001), and instant food consumption (p<0.001) has a significant consequence of hypertension.

The results of research can be used as a consideration for creating programs and policies to control risk factors or hypertension among young adults in Indonesia. Promotive and preventive policies programs related to hypertension must reach the community to reduce hypertension morbidity and mortality rates. Competing Interest Statement The authors have declared no competing interest. Funding Statement This study was funded by LPPM UNNES Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: N/A I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present study are available upon reasonable request to the authors